参考文献/References:
[1] Janvin CC,Aarsland D,Larsen JP.Cognitive predictors of dementia in Parkinson’s disease: a community-based, 4-year longitudinal study[J].J Geriatr Psychiatry Neurol,2005,18(3):149-154.
[2] Chaudhuri KR,Schapira AH.Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment[J].The Lancet Neurology,2009,8(5):464-474.
[3] Tolosa E,Gaig C,Santamar a J,et al.Diagnosis and the premotor phase of Parkinson disease[J].Neurology,2009,72(7 Suppl):S12-S20.
[4] Martinez-Martin P,Rodriguez-Blazquez C,Kurtis MM,et al.The impact of Non-Motor symptoms on Health-Related quality of Life of patients with parkinson’s disease[J].Movement Disorders,2011,26(3):399-406.
[5] Caviness JN,Driver-Dunckley E,Connor DJ,et al.Defining mild cognitive impairment in Parkinson’s disease[J].Mov Disord,2007,22(9):1272-1277.
[6] Petersen RC,Smith GE,Waring SC,et al.Mild cognitive impairment: clinical characterization and outcome[J].Arch Neurol,1999,56(3):303-308.
[7] Petersen RC.Mild cognitive impairment as a diagnostic entity[J].J Intern Med,2004,256(3):183-194.
[8] Kehagia AA,Barker RA,Robbins TW.Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease[J].The Lancet Neurology,2010,9(12):1200-1213.
[9] Janvin CC,Larsen JP,Aarsland D,et al.Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia[J].Mov Disord,2006,21(9):1343-1349.
[10] Aarsland D,Bronnick K,Williams-Gray C,et al.Mild cognitive impairment in Parkinson disease A multicenter pooled analysis[J].Neurology,2010,75(12):1062-1069.
[11] Aarsland D,Andersen K,Larsen JP,et al.Risk of dementia in Parkinson’s disease: a community-based, prospective study[J].Neurology,2001,56(6):730-736.
[12] 王晓君,罗蔚锋,王丽君,等.帕金森病患者认知功能与尿酸及相关因素分析[J].中华医学杂志,2009,89(23):1633-1635.
[13] Aarsland D,Kval?y JT,Andersen K,et al.The effect of age of onset of PD on risk of dementia[J].J Neurol,2007,254(1):38-45.
[14] Aarsland D,Andersen K,Larsen JP,et al.The rate of cognitive decline in Parkinson disease[J].Arch Neurol,2004,61(12):1906-1911.
[15] Evans JR,Mason SL,Williams-Gray CH,et al.The natural history of treated Parkinson’s disease in an incident, community based cohort[J].J Neurol Neurosurg Psychiatry,2011,82(10):1112-1118.
[16] Zgaljardic DJ,Foldi NS,Borod JC.Cognitive and behavioral dysfunction in Parkinson’s disease: neurochemical and clinicopathological contributions[J].J Neural Transm,2004,111(10/11):1287-1301.
[17] Sabbagh MN,Adler CH,Lahti TJ,et al.Parkinson disease with dementia: comparing patients with and without Alzheimer pathology[J].Alzheimer Dis Assoc Disord,2009,23(3):295-297.
[18] Dirnberger G,Jahanshahi M.Executive dysfunction in Parkinson’s disease: a review[J].J Neuropsychol,2013,7(2):193-224.
[19] Kudlicka A,Clare L,Hindle JV.Executive functions in Parkinson’s disease: systematic review and meta-analysis[J].Mov Disord,2011,26(13):2305-2315.
[20] Bohnen NI,Koeppe RA,Minoshima S,et al.Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study[J].J Nucl Med,2011,52(6):848-855.
[21] Nobili F,Abbruzzese G,Morbelli S,et al.Amnestic mild cognitive impairment in Parkinson’s disease: a brain perfusion SPECT study[J].Mov Disord,2009,24(3):414-421.
[22] Johnson DK,Galvin JE.Longitudinal changes in cognition in Parkinson’s disease with and without dementia[J].Dement Geriatr Cogn Disord,2011,31(2):98-108.
[23] Muslimovic’ D,Post B,Speelman JD,et al.Cognitive decline in Parkinson’s disease: a prospective longitudinal study[J].J Int Neuropsychol Soc,2009,15(3):426-437.
[24] Whittington CJ,Podd J,Stewart-Williams S,et al.Memory deficits in Parkinson’s disease[J].J Clin Exp Neuropsychol,2006,28(5):738-754.
[25] Leplow B,Dierks C,Herrmann P,et al.Remote memory in Parkinson’s disease and senile dementia[J].Neuropsychologia,1997,35(4):547-557.
[26] Lewis SJ,Cools R,Robbins TW,et al.Using executive heterogeneity to explore the Nature of working memory deficits in Parkinson’s disease[J].Neuropsychologia,2003,41(6):645-654.
[27] Saxena M,Behari M,Kumaran SS,et al.Assessing speech dysfunction using BOLD and acoustic analysis in parkinsonism[J].Parkinsonism Relat Disord,2014,20(8):855-861.
[28] Litvan I,Goldman JG,Tr ster AI,et al.Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines[J].Mov Disord,2012,27(3):349-356.
[29] Emre M,Aarsland D,Brown R,et al.Clinical diagnostic criteria for dementia associated with Parkinson’s disease[J].Movement Disorders,2007,22(12):1689-1707.
[30] Duda JE,Giasson BI,Mabon ME,et al.Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases[J].Ann Neurol,2002,52(2):205-210.
[31] Aarsland D,Ballard C,Larsen JP,et al.A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson’s disease with and without dementia[J].Int J Geriatr Psychiatry,2001,16(5):528-536.
[32] Burn DJ,Rowan EN,Minett T,et al.Extrapyramidal features in Parkinson’s disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study[J].Mov Disord,2003,18(8):884-889.
[33] Adamec E,Chang HT,Stopa EG,et al.Tau protein expression in front temporal dementias[J].Neurosec Letter,2001,315(1):21-24.
[34] 王维治.神经病学[M].北京:人民卫生出版社,2013.
[35] Rolinski M,Fox C,Maidment I,et al.Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease[J].Cochrane Database Syst Rev,2012,3(3):CD006504.
[36] Emre M,Aarsland D,Albanese A,et al.Rivastigmine for dementia associated with Parkinson’s disease[J].N Eng J Med,2004,351(15):2509-2518..
[37] Weintraub D,Somogyi M,Meng X.Rivastigmine in alzheimer’s disease and parkinson’s disease dementia: an ADAS-cog factor analysis[J].Am J Alzheimers Dis Other Demen,2011,26(6):443-449.
[38] Dubois B,Tolosa E,Katzenschlager R,et al.Donepezil in parkinson’s disease dementia: a randomized, double-blind efficacy and safety study[J].Mov Disord,2012,27(10):1230-1238.
[39] Stubendorff K,Larsson V,Ballard C,et al.Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson’s disease with dementia: a prospective study[J].BMJ Open,2014,4(7):e005158.
[40] Benabid AL.Deep brain stimulation for Parkinson’s disease[J].Curr Opin Neurobiol,2003,13(6):696-706.
[41] Hwynn N,Ul Haq I,Malaty IA,et al.Effect of deep brain stimulation on parkinson’s nonmotor symptoms following unilateral DBS: A pilot study[J].Parkinsons Dis,2011,9(16):1-4.
[42] Parsons TD,Rogers SA,Braaten AJ,et al.Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s disease: a meta-analysis[J].The Lancet Neurology,2006,5(7).